ADAM10 expression and promoter haplotype in Alzheimer's disease.

Neurobiology of Aging
L M BekrisChang-En Yu

Abstract

Alzheimer's disease is confirmed at autopsy according to the accumulation of brain neuritic plaques and neurofibrillary tangles in the brain. Neuritic plaques contain amyloid-β (Aβ) and lower levels of Aβ correspond to an increase in ADAM10 α-secretase activity. ADAM10 α-secretase activity produces a soluble amyloid precursor protein (APP) alpha (sAPPα) product and negates the pathological production of Aβ. In this investigation, it was hypothesized that genetic variation with the ADAM10 promoter is associated with ADAM10 expression levels as well as cerebrospinal fluid sAPPα levels. Results from this investigation suggest that the ADAM10 rs514049-rs653765 C-A promoter haplotype is associated with: (1) higher CSF sAPPα levels in cognitively normal controls compared with Alzheimer's disease (AD) patients, (2) higher postmortem brain hippocampus, but not cerebellum, ADAM10 protein levels in subjects with low plaque scores compared with those with high plaque scores, and (3) higher promoter activity for promoter-only reporter constructs compared with promoter 3' untranslated region (3'UTR) constructs in the human neuroblastoma SHSY5Y cell line, but not in HepG2 or U118 cell lines. Taken together, these findings suggest that ADAM10...Continue Reading

References

Nov 20, 2002·Neuroreport·Luisa Benerini GattaDario Finazzi
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Jun 24, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claudia PrinzenRolf Postina
Dec 6, 2005·Alzheimer Disease and Associated Disorders·Elaine R PeskindDouglas Galasko
Apr 9, 2008·Current Alzheimer Research·Rolf Postina
Mar 30, 2010·The Journal of Biological Chemistry·Sven LammichChristian Haass
Apr 13, 2010·Neurobiology of Aging·Guiqing CaiJoseph D Buxbaum
May 13, 2011·Current Opinion in Genetics & Development·Gabriele SiegelGerhard Schratt
Aug 10, 2011·Archives of Neurology·Clifford R JackUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 15, 2011·Nucleic Acids Research·Kate R RosenbloomW James Kent

❮ Previous
Next ❯

Citations

Jun 1, 1965·Journal of the American Oil Chemists' Society·J F BERRYR R WADE
Apr 23, 2013·Amino Acids·H-G BernsteinG Reiser
Aug 30, 2014·Epilepsy Currents·Elizabeth M Powell
Jul 30, 2015·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Patricia Regina ManzineMárcia Regina Cominetti
Jul 26, 2016·Frontiers in Neurology·Hua TaoKeshen Li
Aug 7, 2016·Aging and Disease·Murat Serdar GursesSumeyya Akyol
Apr 19, 2015·Critical Care : the Official Journal of the Critical Care Forum·Lili CuiKeshen Li
Apr 15, 2017·Journal of Alzheimer's Disease : JAD·Xiang-Zhen YuanLan Tan
Oct 24, 2017·BioMed Research International·Lin-Lin WangShui-Long Guo
May 16, 2019·Journal of Cellular and Molecular Medicine·Xu ZhouKeshen Li
Feb 3, 2021·The Journal of Gene Medicine·Miaomiao ZhouPingyi Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.